Basilea Pharmaceutica AG Stock
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
11:31:48 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 64.10 CHF | -2.29% |
|
-0.62% | +17.18% |
| 08-18 | Basilea Pharmaceutica Ag Raises Earnings Guidance for the Full Year 2026 | CI |
| 08-18 | Swiss Market Index Closes Higher; Huber+Suhner Shares Drop | MT |
| Market Cap | 796M 983M 846M 727M 1.36B 92.83B 1.36B 9.41B 3.65B 47.63B 3.69B 3.61B 153B | P/E 2026 * |
18.9x | P/E 2027 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise Value | 646M 798M 687M 590M 1.1B 75.33B 1.11B 7.63B 2.96B 38.65B 3B 2.93B 125B | EV / Sales 2026 * |
2.48x | EV / Sales 2027 * | 2.15x |
| Free-Float |
91.74% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| BSLN | Delayed | |
CBOE
| 0QNA | Real-time | |
|
Deutsche Boerse AG
| PK5 | Delayed | |
|
London S.E.
| 0QNA | Delayed | |
|
OTC Markets
| BPMUF | Delayed | |
|
Tradegate
| PK5 | Real-time | |
|
Börse Stuttgart
| PK5 | Delayed | |
|
Boerse Muenchen
| PK5 | Real-time |
Last Transcript : Basilea Pharmaceutica AG
| 1 day | -2.29% | ||
| 1 week | -0.62% | ||
| Current month | +0.94% | ||
| 1 month | +26.43% | ||
| 3 months | +28.97% | ||
| 6 months | +22.10% | ||
| Current year | +17.18% |
| 1 week | 62.6 |  | 67.4 |
| 1 month | 51.4 | | 67.4 |
| Current year | 47.8 | | 67.4 |
| 1 year | 44.7 | | 67.4 |
| 3 years | 32 | | 67.4 |
| 5 years | 29.55 | | 67.4 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 2018-04-18 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 2019-04-09 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 2018-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 2011-11-28 |
| Chairman | 71 | 2013-04-08 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/29/26 | Sell | -400 | 0.0030% | |||
| 5/13/26 | Sell | -1,043 | 0.0078% | |||
| 5/4/26 | Sell | 400 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.29% | -0.62% | +36.82% | +35.95% | 983M | |
| -2.54% | -2.84% | -1.77% | +14.72% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +523.39% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +21.22% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +74.90% | 40.73B | |
| +0.53% | -1.36% | +16.87% | +47.12% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +123.04% | 16.5B | |
| -1.01% | +0.50% | +13.91% | +31.45% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.22% | 13.77B | |
| Average | -1.06% | +0.42% | +69.91% | +101.45% | 27.6B | |
| Weighted average by Cap. | -1.04% | +0.11% | +89.22% | +127.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 261M 322M 277M 238M 445M 30.4B 447M 3.08B 1.2B 15.6B 1.21B 1.18B 50.24B | 271M 334M 288M 247M 462M 31.55B 464M 3.2B 1.24B 16.19B 1.25B 1.23B 52.14B |
| Net income | 53.56M 66.15M 56.92M 48.92M 91.52M 6.25B 91.77M 633M 246M 3.2B 248M 243M 10.32B | 44.43M 54.88M 47.22M 40.59M 75.93M 5.18B 76.13M 525M 204M 2.66B 206M 202M 8.56B |
| Net Debt | -150M -185M -160M -137M -256M -17.5B -257M -1.77B -688M -8.98B -696M -681M -28.93B | -214M -264M -227M -195M -365M -24.92B -366M -2.53B -980M -12.79B -991M -970M -41.19B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | CHF 64.10 | -2.29% | 34,162 |
| 26-09-03 | CHF 65.60 | -0.15% | 42,090 |
| 26-09-02 | CHF 65.70 | +3.79% | 108,913 |
| 26-09-01 | CHF 63.30 | -0.31% | 39,067 |
| 26-08-31 | CHF 63.50 | -1.55% | 45,150 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
